Apps that track your use of GLP-1s have become their own little niche in the health-related app market. Some are focused on reminders and dose history, while others try to help users track weight loss, side effects, nutrition, hydration and the general peptide use experience that comes with drugs like semaglutide and tirzepatide.
In this MeAgain vs Shotsy comparison, we’ll be looking at two apps that are primarily geared toward GLP-1 users. Both of them approach peptide tracking from quite different angles.
MeAgain is more about lifestyle, progress, food, and symptoms. Shotsy is more about the compounds themselves - it’s more focused on logs, charts and structured tracking. That said, which one is the better option for your needs? Well - let’s find out!
Want to track more than GLP-1s? Peptides AI is the better overall choice for users wanting a more comprehensive peptide tracker, wellness data, and AI-powered insights, all in one place.
| Meagain | Shotsy | |
|---|---|---|
| Main focus | GLP-1 lifestyle and progress tracking | GLP-1 medication and dose tracking |
| Best for | Users who want food, symptoms, weight, and photos in one place | Users who want logs, reminders, charts, and structured medication history |
| Dose tracking | ✅ | ✅ |
| Injection reminders | ✅ | ✅ |
| Nutrition tracking | Stronger | More limited |
| Water tracking | ✅ | ✅ |
| Side effect tracking | ✅ | ✅ |
| Weight tracking | ✅ | ✅ |
| Progress photos | ✅ | Limited |
| Charts & data | Limited | Stronger |
| Overall scope | Broader lifestyle support | More focused medication tracking |
In short, the MeAgain vs Shotsy debate boils down to two different ways of looking at GLP-1 peptide tracking.
MeAgain is more like an “everyday buddy” app. It's about the broader experience of being on GLP-1s, not just the shots themselves. That means protein, water, side effects, and progress photos play a bigger part in the overall value of the app.
Shotsy, on the other hand, is more about the peptide side of things. It's more for people who want to keep their shot history neat, follow dose schedules, review progress data, and use charts to understand what has been going on over time.
The Shotsy vs MeAgain discussion kind of boils down to what you want to track. MeAgain provides more lifestyle context, while Shotsy makes it easier to track your medication in a more structured way.
Before getting into the specifics, let’s place the two apps next to each other, and do a broader feature overview:
| MeAgain | Shotsy | |
|---|---|---|
| Injection logging | ✅ | ✅ |
| Reminders | ✅ | ✅ |
| Custom schedules | Limited | Limited |
| Recurring doses | ✅ | ✅ |
| Missed dose logging | Limited | ✅ |
| Calendar view | Limited | ✅ |
| Weight tracking | ✅ | ✅ |
| Progress photos | ✅ | ❌ |
| Symptom tracking | ✅ | ✅ |
| Body composition tracking | Limited | ❌ |
| Health metrics | ✅ | Limited |
| Health app integrations | Limited | ✅ |
| Data export | Limited | ✅ |
| Multi-peptide support | ❌ | Limited |
| Peptide calculator | ❌ | ❌ |
| Reconstitution tools | ❌ | ❌ |
| Inventory tracking | ❌ | ❌ |
As you can see, there's some overlap. Both apps can help you log injections, set reminders, track weight and side effects. Both are, therefore, useful to people on semaglutide, tirzepatide, or similar GLP-1-based peptides.
But once you get past the basics, that’s where the differences start to emerge.
MeAgain is more interested in the everyday context. Weight, progress pics, symptoms, meals, protein, hydration, and general habit building are more central to the experience. Shotsy, on the other hand, is more about logs, recurrent and missed doses, calendar views, data export, health app integrations, etc.
One way to put it is that MeAgain aims to be helpful all day long, while Shotsy wants to keep your peptide tracking clean and tidy.
Nothing wrong with either. In fact, both apps would suffice for many GLP-1 users. If you only need to remember injections and monitor weight changes, they can both handle this.
The problem is that both apps start to feel more limited when you put them up against a more diverse ecosystem of peptide trackers. Neither app is very good for advanced peptide stack management, peptide calculations, reconstitution tracking, inventory management, or AI-based features.
In a Shotsy vs MeAgain comparison, you’re mainly choosing between lifestyle-based vs medication-based GLP-1 tracking. However, apps like Peptides AI open up a much larger scope of features for you to explore and utilize.
So, MeAgain and Shotsy are useful GLP-1 apps with different strengths. And, as far as this comparison is concerned, those strengths are exactly what’s worth taking a closer look at.
GLP-1 tracking is not one thing.
For some users, it’s really all about remembering the next injection. For others, it's a full-body project of appetite, digestion, protein intake, fatigue, hydration, and the weird emotional math of trying to figure out if progress is actually happening.
So let’s stop pretending this is a clean, one-click verdict and break the comparison down by category.
| MeAgain | Shotsy | |
|---|---|---|
| Injection logging | ✅ | ✅ |
| Dose history | ✅ | ✅ |
| Injection reminders | ✅ | ✅ |
| Recurring doses | ✅ | ✅ |
| Custom schedules | Limited | Limited |
| Missed dose logging | Limited | ✅ |
| Calendar view | Limited | ✅ |
| Multi-peptide support | ❌ | Limited |
| Peptide calculator | ❌ | ❌ |
Both apps cover the basics here. If you’re on a weekly GLP-1 regimen and just want to remember when you took your last dose, either MeAgain or Shotsy will work.
That said, this is the first area where Shotsy starts to get ahead. In the initial comparison of the two peptide trackers, Shotsy was a bit better in features related to scheduling, such as logging missed doses and calendar view. That makes it the better choice for users who want their medication history to feel clean, neat, and easy to revisit.
MeAgain still handles the basics well. Track doses, stay on top of reminders, and keep your GLP-1 routine from becoming a messy notes-app situation. That will suffice for a lot of users.
The bad news is that MeAgain’s peptide tracking is not the app’s best feature. It feels more like part of a larger lifestyle tracker. Useful, but not really deep.
Shotsy will likely be better for people who care about questions such as:
That makes it a nice setup for GLP-1 users who want to keep things simple. But the Shotsy vs MeAgain comparison also shows the limitations of both apps. Neither is very potent for advanced peptide use. No proper peptide calculators, no serious multi-peptide stack management, no reconstitution workflow - you’ll need to look for external sources for these and similar advanced features.
| MeAgain | Shotsy | |
|---|---|---|
| Food tracking | ✅ | Limited |
| Protein tracking | ✅ | Limited |
| Fiber tracking | ✅ | Limited |
| Water tracking | ✅ | ✅ |
| Weight-related nutrition context | ✅ | Limited |
| Lifestyle habit tracking | ✅ | Limited |
This is one of the most obvious areas of difference in the MeAgain vs Shotsy comparison.
GLP-1 drugs affect appetite, meal sizes, cravings, digestion, hydration, and in many instances, the ability of the user to eat enough protein without feeling like they are competing in a sport.
That’s why tracking nutrition is so important in this category[1]. A GLP-1 app that just reminds you when to take your next injection can be useful, but it doesn’t answer the more practical day-to-day questions:
MeAgain is more powerful here. It's built around the everyday GLP-1 experience, and nutrition is a big part of that. The app is optimized in such a way that tracking food, protein, fiber, and water all feel seamless.
That makes MeAgain more valuable for users who want to connect their medication journey with the lifestyle changes that are going on around it. This is especially true for people who are on GLP-1s for weight loss, where the scale doesn’t necessarily tell the full story.
Shotsy doesn’t completely overlook this side of things, though. Water intake tracking is there, and you get some wellness context in the overall experience. But nutrition isn’t the main reason anyone would pick up this app. I’d describe Shotsy as a peptide tracker with some progress and health-support features attached, rather than a lifestyle app with food and habits at its core.
So in this MeAgain vs Shotsy comparison category, the former wins.
If you want your tracker to reflect the reality of GLP-1 use, not just the injection schedule, MeAgain is the better choice. Avid peptide users often deal with changes in appetite, hydration, protein intake, and digestion. MeAgain makes more room for those things.
| MeAgain | Shotsy | |
|---|---|---|
| Symptom tracking | ✅ | ✅ |
| Side effect tracking | ✅ | ✅ |
| Severity tracking | ✅ | Limited |
| Daily lifestyle context | ✅ | Limited |
| Medication-centered context | Limited | ✅ |
| Pattern spotting | ✅ | ✅ |
You can have the best injection schedule in the world, but if you are dealing with nausea, constipation, reflux, fatigue, headaches, or random “why do I feel like sh*t today?” moments, reminders alone won’t do much for you. This is where a tracker has to be more than an overglorified calendar.
In the MeAgain vs Shotsy comparison, both apps provide symptom and side effect tracking. The difference is how that info plays with the rest of the app.
If you want to understand side effects as part of your daily routine, MeAgain is better. Symptoms have more context around them, since the app also covers nutrition, water, weight, and progress tracking. That matters because side effects don't happen in a vacuum.
For example, you may have worse nausea on days when you eat less. Constipation may be connected to low water or fiber intake. Fatigue can occur around changes in dose, calories, or inconsistent eating. Obviously, a tracker can’t diagnose those patterns for you, but it can make them easier to see.
Shotsy has a more medication-centric view of side effects. If you want to go back and see how symptoms relate to timing of doses, shot history, or changes in your medication routine, the Shotsy structure makes sense.
As far as this Shotsy vs MeAgain comparison is concerned, choose MeAgain if you want symptoms to be next to food, water, weight, and habit tracking. If you want a clean medication record and understand symptoms in correlation with your dosing schedule, pick Shotsy instead.
Just keep in mind that the same broader limitation still applies. Both apps are useful tools for tracking GLP-1 side effects, but neither seems to be the most compelling option for users interested in linking symptoms to broader peptide use, body composition, training, nutrition, and long-term health metrics.
This is another area where apps like Peptides AI have the advantage. If you’re tracking more than one GLP-1s, side effects are just one piece of the larger puzzle. Peptides AI offers more room for that bigger picture.
| MeAgain | Shotsy | |
|---|---|---|
| Weight tracking | ✅ | ✅ |
| Progress photos | ✅ | ❌ |
| Visual progress tools | ✅ | Limited |
| Lifestyle context | ✅ | Limited |
| Progress charts | Limited | ✅ |
The main reason people are looking for apps like these, in the first place, is for weight loss[2]. Of course, not everyone taking GLP-1s is doing so for that reason, but a large share of the user base is. This makes progress tracking a pretty important part of the MeAgain vs Shotsy comparison, or any peptide app comparison, for that matter.
Both apps allow users to track changes in weight. That’s the baseline. The difference is in what they do around that number.
MeAgain is better for seeing progress. Progress photos are a notable feature here, because they give users one more way to see change over time. Pictures are not a replacement for proper body composition tracking, but they can help users to see trends that the scale can’t show. That’s motivating to a lot of people.
Shotsy takes a more structured approach to progress. Better for users who want charts, weight history, and progress data linked to compound use. That can be very helpful, particularly if you’re worried about the link between dose changes, shot timing or consistency, and weight trends.
That said, neither app offers more detailed body composition tracking, however. That’s worth keeping in mind.
| MeAgain | Shotsy | |
|---|---|---|
| Weight trend tracking | ✅ | ✅ |
| Medication level visualization | Limited | ✅ |
| Dose-related progress charts | Limited | ✅ |
| Lifestyle-based insights | ✅ | Limited |
| Symptom pattern context | ✅ | ✅ |
If you are looking for a more data-driven GLP-1 tracker, Shotsy is better - simple as that. Its analytics have a larger focus on visualizing progress, dose timing, and medication-related changes over time.
The app has a feature that offers users a way to see how much of a compound could still be active in their system between shots. This can be really helpful for those who like to correlate patterns between dose days, side effects, appetite changes, and weight fluctuations.
MeAgain isn’t trying to be the more technical charting app. Users can utilize a few different features to build a more complete picture of what their GLP-1 journey looks like.
So, the verdict here is pretty clean - Shotsy wins for charts and data management.
Ease of use isn’t simple to measure, because “easy” doesn’t mean the same thing to everyone.
Some users want as little friction as they can. Open app, log shot, view next reminder, close app. Done. For that kind of user, Shotsy’s more targeted setup can be more attractive. It doesn’t try to make every minute of your life a part of the tracking experience.
Other users want an app that feels more engaging. They want to track everything. For those users, MeAgain is more suitable because it mirrors what they actually want to keep track of.
So, in other words, it really just depends on your personal preferences. If you want structure, Shotsy is easier. MeAgain is better if you need more context.
Both apps are user-friendly enough for beginners. So, in terms of ease of use, the MeAgain vs Shotsy app question is about which one makes your own workflow feel less scattered.
| MeAgain | Shotsy | |
|---|---|---|
| iOS support | ✅ | ✅ |
| Android support | ✅ | ✅ |
| Apple Health integration | Limited | ✅ |
| Google Health integration | Limited | ✅ |
| Cross-device accessibility | Limited | ✅ |
| Cell 6,1 | ✅ | ✅ |
Accessibility is a boring feature - until it becomes a problem.
You can have all the smart charts and slick screens in the world, but if a tracker doesn’t fit within your actual device setup, it becomes annoying fast. Usually, GLP-1 tracking is a long-term thing. Users aren’t logging one injection and walking away. They’re tracking weeks or months of progress, dose changes, side effects, habits, and so much more.
The good news is that both apps in this MeAgain vs Shotsy comparison are available on iOS and Android. That said, Shotsy appears to have an edge with integrations and data exports. It can make it more useful for users who want their GLP-1 data to connect to other health information, or who want the option to move records out of the app.
Exportability is useful when you’re talking to your healthcare provider, switching peptides, reviewing side effects, or trying to understand your weight trend over several months. A tracker shouldn’t feel like a locked drawer where your own data disappears when you close the app.
So, on the more technical side of the comparison, Shotsy wins in terms of integrations and accessibility. MeAgain is still widely available and easy to use, though.
| MeAgain | Shotsy | |
|---|---|---|
| Weekly | - | - |
| Monthly | $9.99 | $9.99 |
| Annual | $99.99 | $39.99 |
Both apps cost $9.99 per month, which makes the short-term decision pretty simple. If you only want to try one for a month, price probably shouldn’t be the deciding factor.
The annual pricing is where the difference becomes much sharper.
Shotsy costs $39.99 per year, while MeAgain costs $99.99 for the annual subscription. That’s not a small gap. But the big pricing question in this Shotsy vs MeAgain discussion is whether you want to pay for a medication tracker, or a more complete GLP-1 lifestyle app.
At this point, the MeAgain vs Shotsy comparison is pretty clear.
MeAgain is better for GLP-1 users who want lifestyle context, Shotsy is better for those who want a more structured medication tracker. Both are useful, but both are also limited in similar ways - they are essentially built around GLP-1 tracking, not broader peptide management.
That is where Peptides AI becomes the leading alternative here.
| MeAgain | Shotsy | Peptides AI | |
|---|---|---|---|
| Main focus | GLP-1 lifestyle tracking | GLP-1 medication tracking | Peptide and wellness tracking |
| iOS & Android support | ✅ | ✅ | ✅ |
| Injection logging | ✅ | ✅ | ✅ |
| Custom protocols | Limited | Limited | ✅ |
| Multi-peptide support | ❌ | Limited | ✅ |
| Injection site tracking | ❌ | ❌ | ✅ |
| Dose history | ✅ | ✅ | ✅ |
| Peptide calculator | ❌ | ❌ | ✅ |
| Inventory tracking | ❌ | ❌ | ✅ |
| Reconstitution tools | ❌ | ❌ | ✅ |
| Expiration tracking | ❌ | ❌ | ✅ |
| Weight tracking | ✅ | ✅ | ✅ |
| Progress photos | ✅ | ❌ | ✅ |
| Body composition tracking | Limited | ❌ | ✅ |
| Symptom tracking | ✅ | ✅ | ✅ |
| Nutrition tracking | ✅ | Limited | ✅ |
| Training tracking | ❌ | ❌ | ✅ |
| AI insights | Limited | Limited | ✅ |
| Health metrics | ✅ | Limited | ✅ |
| Data export | Limited | ✅ | ✅ |
| Monthly price | $9.99 | $9.99 | $12.99 |
| Annual price | $99.99 | $39.99 | $34.99 |
MeAgain and Shotsy are good if your tracking needs are in the GLP-1 lane. If you are mostly on semaglutide or tirzepatide and want to track weight, symptoms, reminders, and basic medication history, either app can make sense.
But peptide tracking tends to be more complicated than this.
Some people want to use custom protocols. Others want to work with more than one compound at a time. Some need a peptide calculator, reconstitution tools, vial tracking, expiration tracking, inventory alerts, and a way to link peptide use to broader health data.
Peptides AI is more powerful than the two apps discussed in this article because it's built around the broader peptide / wellness use case. It’s one of the most complete peptide tracker apps overall, with tools for protocol management, reminders, inventory, reconstitution, body composition, nutrition, training, health metrics, and AI-powered insights.
Why is that? Because a good tracker should help you address questions like:
MeAgain answers some of those questions from a “buddy app” perspective. Shotsy answers the same questions from a medication-tracking point of view. Peptides AI combines those two perspectives, and takes it a step further.
With all of its advanced features, you’d think Peptides AI is going to be expensive. Well, the app is great in this regard, as well - it features a weekly plan, and the monthly and annual options offer a fantastic price vs quality ratio, considering what you get for the money.
In short, if you want the most comprehensive peptide tracking platform, Peptides AI is the leading option on the market right now. It’s not just another MeAgain vs Shotsy app alternative - instead, it’s a more sophisticated tracker for users who want peptide management, health optimization, and progress tracking all in one ecosystem.
And so, that’s the MeAgain vs Shotsy comparison!
To sum things up, if you want a GLP-1 tracker that takes into account things like food, water, symptoms, and progress photos, MeAgain is a good option. If you want cleaner peptide tracking, reminders, charts, calendar structure, and more value on the annual plan, Shotsy is better.
However, if you want a full wellness ecosystem or are looking to track more than just GLP-1 compounds, Peptides AI is still the better overall option.
Thanks for reading, and I’ll see you in the next one!
Verified
Verified
If you want a more lifestyle-focused GLP-1 tracker, MeAgain might be better than Shotsy. It’s more powerful for tracking food, protein, fiber, water, symptoms, weight changes, and progress photos. Shotsy is more focused on the technical side of things. That being said, Peptides AI is considered the better option, compared to both of the aforementioned apps.
MeAgain is more like a GLP-1 lifestyle partner app, while Shotsy is more of a GLP-1 peptide tracker. MeAgain is more focused on nutrition, side effects, progress photos, and habits. Shotsy focuses more on dose history, schedules, charts, and tracking structure.
Both apps allow you to track side effects, but they do so in different ways. If you want to match symptoms with nutrition, weight loss, and daily habits, MeAgain is better. Shotsy is better if you want to look at symptoms from a medication perspective (especially regarding dose timing and shot history).
MeAgain is better for tracking food, protein, fiber, and water intake. Shotsy does have some wellness tracking, but nutrition is not its strong suit. It’s more of a medication-first tracker, as opposed to an app for tracking food or habits.
The monthly subscription price is the same for both apps - $9.99 per month. However, the price per year is very different. MeAgain costs $99.99 for the annual sub, while Shotsy costs $39.99. That makes Shotsy the more budget-friendly choice when you’re comparing the annual plans side-by-side.
If you want more than just basic GLP-1 tracking, Peptides AI is the better overall option. The app provides a wider range of peptide-related tools, such as custom protocols, multi-peptide support, peptide calculations, inventory tracking, reconstitution tools, body composition, nutrition, training, health metrics, and AI features.
Join 60,000+ longevity biohackers and get our 5-min weekly read with the latest findings, research-backed protocols and tips to boost your daily habbits!
Searching for results...
Please wait while we find the resultsNo results found for ""
Try searching for a different termSomething went wrong
Please try again later